Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 7Rectal Neoplasms 3Colorectal Neoplasms 3Colonic Neoplasms 3Stomach Neoplasms 2Neoplasm, Residual 2Mesothelioma, Malignant 2Uterine Cervical Neoplasms 1Turcot syndrome 1Solitary Fibrous Tumor, Pleural 1Sarcopenia 1Sarcoglycanopathies 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Pancreatic Neuroendocrine Tumors (pNET) 1Pancreatic Neoplasms 1Nasopharyngeal Carcinoma 1NSCLC 1Microsatellite Instability 1Mesothelioma 1Melanoma 1Malnutrition 1Lung Neoplasms 1HER2 Negative Breast Cancer 1Glioblastoma 1Gastrointestinal Neoplasms 1Frailty 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1

Interventions

Temozolomide 99Radiotherapy 51Magnetic Resonance Spectroscopy 38Radiation 28Specimen Handling 25pembrolizumab 23Bevacizumab 20Lomustine 16Nivolumab 14Surgical Procedures, Operative 11Cyclophosphamide 8Biopsy 8atezolizumab 7abemaciclib 7Ipilimumab 7fludarabine 6Radiotherapy, Intensity-Modulated 6Carboplatin 6olaparib 5Metformin 5Diet, Ketogenic 5Dianhydrogalactitol 5Aminolevulinic Acid 5regorafenib 4poly ICLC 4Radiosurgery 4Photons 4Leukapheresis 4Immunoglobulin G 4Etoposide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioblastoma × Chemotherapy, Adjuvant × 1 year × Clear all
NCT04747145 2025-08-21

Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma

Medical College of Wisconsin

Phase 2 Active not recruiting
38 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡